UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1326
Cactus
WHD
$5.27B
| $8.27M | ﹤0.01% |
161,335
-24,477
| -13% | -$1.36M |
2018 Q3
31 quarters
|
|
1327
Abercrombie & Fitch
ANF
$6.98B
| $8.26M | ﹤0.01% |
91,784
-45
| -0% | -$3.82K |
2013 Q2
52 quarters
|
|
1328
Korn Ferry
KFY
$4.28B
| $8.25M | ﹤0.01% |
123,977
+5,352
| +5% | +$362K |
2013 Q2
52 quarters
|
|
1329
Federated Hermes
FHI
$4.37B
| $8.22M | ﹤0.01% |
148,924
-4,645
| -3% | -$263K |
2020 Q1
25 quarters
|
|
1330
Urban Outfitters
URBN
$7.77B
| $8.22M | ﹤0.01% |
115,936
-566
| -0.5% | -$40.3K |
2013 Q2
52 quarters
|
|
1331
H.B. Fuller
FUL
$2.68B
| $8.21M | ﹤0.01% |
140,921
+13,441
| +11% | +$827K |
2013 Q2
52 quarters
|
|
1332
Pitney Bowes
PBI
$2.21B
| $8.21M | ﹤0.01% |
468,595
+79,226
| +20% | +$1.21M |
2013 Q2
52 quarters
|
|
|
SILA
1333
DELISTED
Sila Realty Trust
SILA
| $8.21M | ﹤0.01% |
270,284
+11,675
| +5% | +$341K |
2024 Q3
7 quarters
|
|
1334
Universal Display
OLED
$3.78B
| $8.2M | ﹤0.01% |
94,707
-6,913
| -7% | -$638K |
2013 Q2
52 quarters
|
|
1335
ScottsMiracle-Gro
SMG
$3.62B
| $8.2M | ﹤0.01% |
120,380
+3,763
| +3% | +$233K |
2013 Q2
52 quarters
|
|
1336
McGrath RentCorp
MGRC
$2.88B
| $8.17M | ﹤0.01% |
67,515
+583
| +0.9% | +$66.2K |
2023 Q1
13 quarters
|
|
1337
Dave Inc
DAVE
$4.04B
| $8.16M | ﹤0.01% |
21,913
+6,063
| +38% | +$1.58M |
2025 Q1
5 quarters
|
|
1338
RingCentral
RNG
$6.8B
| $8.16M | ﹤0.01% |
209,433
-3,927
| -2% | -$159K |
2014 Q4
46 quarters
|
|
1339
WD-40
WDFC
$2.95B
| $8.13M | ﹤0.01% |
33,377
-4,098
| -11% | -$877K |
2013 Q2
52 quarters
|
|
1340
Chesapeake Utilities
CPK
$3.44B
| $8.11M | ﹤0.01% |
66,220
+551
| +0.8% | +$69.1K |
2014 Q1
49 quarters
|
|
1341
Cogent Biosciences
COGT
$5.38B
| $8.1M | ﹤0.01% |
209,402
+43,892
| +27% | +$1.54M |
2022 Q4
14 quarters
|
|
1342
Travere Therapeutics
TVTX
$4.75B
| $8.09M | ﹤0.01% |
142,368
+5,343
| +4% | +$237K |
2018 Q1
33 quarters
|
|
1343
Cal-Maine
CALM
$2.97B
| $8.07M | ﹤0.01% |
100,208
+3,737
| +4% | +$289K |
2013 Q2
52 quarters
|
|
1344
Insight Enterprises
NSIT
$5.07B
| $8.05M | ﹤0.01% |
66,062
-1,093
| -2% | -$100K |
2013 Q2
52 quarters
|
|
1345
Mirum Pharmaceuticals
MIRM
$5.52B
| $8.05M | ﹤0.01% |
68,725
+2,096
| +3% | +$210K |
2022 Q4
14 quarters
|
|
1346
PJT Partners
PJT
$3.83B
| $8.04M | ﹤0.01% |
53,252
-5,753
| -10% | -$887K |
2017 Q2
36 quarters
|
|
1347
Home BancShares
HOMB
$5.93B
| $8.03M | ﹤0.01% |
281,239
-46,559
| -14% | -$1.26M |
2013 Q2
52 quarters
|
|
1348
Polaris
PII
$3.38B
| $8.01M | ﹤0.01% |
117,084
+12,999
| +12% | +$838K |
2013 Q2
52 quarters
|
|
1349
Indivior Pharmaceuticals
INDV
$4.17B
| $7.99M | ﹤0.01% |
194,687
+193,237
| +13,327% | +$7.01M |
2024 Q2
8 quarters
|
|
1350
Hilton Grand Vacations
HGV
$2.91B
| $7.98M | ﹤0.01% |
152,403
+4,313
| +3% | +$208K |
2017 Q1
37 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.